thank you for your indulgence, mr. chairman. >> mr. boyer? >> i had to take a deep breath because mr. matheson and i and i guess now chairman dingell and gene green -- you know, we've taken this -- trying to educate the committee here on electronic pedigree with regard to drugs, yet, now all of a sudden there's this great interest to do something expansive on pedigree with food. so i just want you to stop and ponder and think about this, mr. chairman, because as we move to the drug safety bill you can't say you have this level of interest to go after tainted foods but with regard to drugs, that's different. we're not going to send this message to the country that tainted food, bad lettuce, that's really awful. but we can have a different standard whether it comes to bad lipitor. i just -- i'm uncomfortable. let me ask some questions because i don't think i completely understand. when i look at section 106 and section 107, we have sort of an all-in and under traceability we have some exemptions. so i'm -- you know, i come from a very small tow